Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/1996
11/06/1996CN1135237A Products that elicit neutralizing antibodies against genetically divergent HIV-1 strains
11/06/1996CN1134941A New pseudopeptides having trifluoromethyl substtuted 2-azazbicyclooctane
11/06/1996CN1134940A New acylated pseudopeptides containing trifluoromethyl-substituted 2-azabicyclooctane
11/06/1996CN1134939A Method for prepn. of 3-formyl-cephem derivatives
11/06/1996CN1134831A Composite pharmaceutics made of oldenlandia and usage thereof
11/06/1996CA2174583A1 Sulfuric acid esters of sugar alcohols
11/05/1996US5571921 Substituted (2-oxo-1-benzimidazolinyl)-peperidines, process for their preparation, and use as anti-retroviral agents
11/05/1996US5571902 Synthesis of oligonucleotides
11/05/1996US5571843 Derivatives of indan-1,3-dione and indan-1,2,3-trione, methods of preparing them and therapeutic use thereof
11/05/1996US5571812 7-amino-1-cyclopropyl-6,8-dihalogeno-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid antibacterial agents
11/05/1996US5571811 Treating helicobacter infection
11/05/1996US5571806 Dibenz[b,f][1,4]oxazepin(and thiazepin)-11(10H)-ones and-thiones and their use in the prevention or treatment of HIV infection
11/05/1996US5571805 Antibiotic compounds
11/05/1996US5571798 Synergistic antiviral nucleoside combinations
11/05/1996US5571795 Glycosylated steroids coupled to a drug, transportation across biological membranes
11/05/1996US5571712 Non-infectious, replication defective, immunogenic HIV retrovirus-like particles produced from a recombinant HIV genome devoid of long terminal repeats
11/05/1996US5571694 Expression of tetanus toxin fragment C in yeast
11/05/1996US5571535 Treatment of topical infections
11/05/1996US5571512 Pharmaceutical composition against AIDS
11/05/1996US5571505 Anti-HIV oligomers
10/1996
10/31/1996WO1996034107A2 Antiviral proteins, dna coding sequences therefor, and uses thereof
10/31/1996WO1996034106A1 Decorin binding protein compositions and methods of use
10/31/1996WO1996034105A1 Modified polypeptides for enhanced immunogenicity
10/31/1996WO1996034103A1 Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes
10/31/1996WO1996034095A1 Human tumor necrosis factor receptors
10/31/1996WO1996034015A1 Modified anti-icam-1 antibodies and their use in the treatment of inflammation
10/31/1996WO1996034010A2 Inhibitors of farnesyl-protein transferase
10/31/1996WO1996033739A1 Vaccines containing a saponin and a sterol
10/31/1996WO1996033738A1 Improved virus vaccines
10/31/1996WO1996033737A1 Peptide-based vaccine against papillomavirus infection
10/31/1996WO1996033730A2 Chemokine binding protein and methods of use therefor
10/31/1996WO1996033720A1 Use of (r)-penciclovir triphosphate for the manufacture of a medicament for the treatment of viral diseases
10/31/1996CA2222283A1 Improved virus vaccines
10/31/1996CA2219105A1 Cyanovirin-n, an anti-hiv protein, dna coding sequences therefor, and uses thereof
10/31/1996CA2218987A1 Modified polypeptides for enhanced immunogenicity
10/31/1996CA2218492A1 Decorin binding protein compositions and methods of use
10/30/1996EP0739981A1 Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes
10/30/1996EP0739902A2 Novel oligoribonucleotide derivatives and application thereof to antiviral agents
10/30/1996EP0739901A2 Novel oligoribonucleotide derivatives and application thereof to antiviral agents
10/30/1996EP0739900A2 Novel oligoribonucleotide derivatives and application thereof to antiviral agents
10/30/1996EP0739899A2 Novel oligoribonucleotide derivatives and application thereof to antiviral agents
10/30/1996EP0739898A2 Phosphonomonoester nucleic acids, methods for their preparation and their use
10/30/1996EP0739415A1 Anti-hepatitis b poly- and oligonucleotides
10/30/1996EP0739414A1 Herpesvirus replication defective mutants
10/30/1996EP0739355A1 Kallikrein-inhibiting "kunitz domain" proteins and analogues thereof
10/30/1996EP0739350A1 Ligand that binds fas antigen
10/30/1996EP0739345A1 Cyclic polyamines
10/30/1996EP0739208A1 Flavin derivatives as anti-viral agents
10/30/1996EP0739205A1 Use of n-alkyl derivatives of 1,5-dideoxy-1,5-imino-d-glucitol for the treatment of hepatitis b virus infections
10/30/1996EP0739202A1 Use of bis(amidinobenzimidazoles) in the manufacture of medicament for inhibiting retroviral integrase
10/30/1996EP0538301B1 Hiv-inhibiting benzeneacetamide derivatives
10/30/1996EP0532595B1 The pharmacological use of certain cystine derivatives
10/30/1996EP0527852B1 Method and compositions for treating injury
10/30/1996CN1134705A Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases
10/30/1996CN1134697A Pyrimidine-thloalkyl and alkylether compounds
10/30/1996CN1134419A N-(3-Benzofuranyl) urea-derivatives
10/30/1996CN1134270A Center dispense suture package
10/30/1996CN1033142C Process for preparing pharmaceutical composition showing properties in against human immunodeficiency virus
10/29/1996US5569760 Reacting 2-chloro-n-/2-chloro-4-methyl-3-pyridyl/-3-pyridine carboxamide with cyclopropylamine in presence of oxide or hydroxide of group 2 element, cyclizing product
10/29/1996US5569672 Human and animal growth promoters; calcium pseudomonate
10/29/1996US5569646 Treatment of pneumonia; microbiocides, fungicides
10/29/1996US5569454 Methods of treating infection using natural killer stimulatory factor
10/29/1996CA1338683C Fatty acid therapy and compositions
10/25/1996EP0712936A4 Low-molecular dna from sturgeon mult, a method of obtaining the dna and a pharmaceutical preparation based on it
10/24/1996WO1996033416A1 Methods of screening for therapeutic agents using novel apoptosis-modulating proteins
10/24/1996WO1996033285A1 Efflux pump inhibitors
10/24/1996WO1996033282A2 High efficiency ex vivo transduction of cells by high titer recombinant retroviral preparations
10/24/1996WO1996033274A1 Helicobacter pylori cagi region
10/24/1996WO1996033268A1 Apopain
10/24/1996WO1996033220A1 Protective helicobacter antigens
10/24/1996WO1996033219A1 Monoclonal antibodies against hiv-1 and vaccines made thereof
10/24/1996WO1996033203A1 Immunopotentiating inosine monophosphate 5'-nucleotidase resistant derivatives and uses thereof
10/24/1996WO1996033200A1 Novel compounds and methods for therapy
10/24/1996WO1996033197A1 Preparation of clavulanate salts
10/24/1996WO1996033187A1 Oxygenated-heterocycle containing sulfonamide inhibitors of aspartyl protease
10/24/1996WO1996033184A1 Thf-containing sulfonamide inhibitors of aspartyl protease
10/24/1996WO1996033172A1 Arylsulfonyl hydroxamic acid derivatives as mmp and tnf inhibitors
10/24/1996WO1996033159A1 Cyclobutane derivatives as inhibitors of squalene synthase and protein farnesyltransferase
10/24/1996WO1996032964A1 Therapeutic composition comprising an antigen or an in vivo generator for generating a compound comprising an amino acid sequence
10/24/1996WO1996032934A1 2,4-dichlorobenzyl alcohol and amylmetacresol against hiv infection
10/24/1996WO1996032841A1 Novel therapeutic binding molecule complexes
10/24/1996CA2218691A1 Novel therapeutic binding molecule complexes
10/24/1996CA2218679A1 Apopain
10/24/1996CA2218648A1 Preparation of clavulanate salts
10/24/1996CA2218597A1 Cyclobutane derivatives as inhibitors of squalene synthase and protein farnesyltransferase
10/24/1996CA2217865A1 Efflux pump inhibitors
10/24/1996CA2217496A1 Protective helicobacter antigens
10/24/1996CA2216871A1 High efficiency ex vivo transduction of cells by high titer recombinant retroviral preparations
10/23/1996EP0738726A1 Heterobenzocyclopentane oxazolidinones having antibacterial activity
10/23/1996EP0738724A2 Process for the preparation of an N-terbutylamide derivative
10/23/1996EP0738328A1 Composition containing nucleic acids, preparation and uses
10/23/1996EP0738273A1 Monohydrate of (e)-2'-deoxy-2'-(fluoromethylene)cytidine
10/23/1996EP0738261A1 Pharmaceutical formulations comprising polythiourea and method of use thereof
10/23/1996EP0738155A1 Modular design and synthesis of oxazolone-derived molecules
10/23/1996EP0738107A1 Inhibitors of fatty acid synthesis as antimicrobial agents
10/23/1996EP0502048B1 Use of caffeine in the treatment of herpes simplex virus infections
10/23/1996CN1134175A Viral vector with bovine viral diarrhea virus (BVDV) antigens
10/23/1996CN1134174A Modified plant viruses as vectors of heterologous peptides
10/23/1996CN1133885A Preparation of alpha-1 antichymotrypsin
10/23/1996CN1033087C 7-(subtd.)-8-(substd.-9-|(substd.glycyl) amido¨-6-demethyl-6-deoxytetracyclines
1 ... 1601 1602 1603 1604 1605 1606 1607 1608 1609 1610 1611 1612 1613 1614 1615 1616 1617 1618 1619 1620 1621 ... 1798